TreatmentCT scan, Diffuse hepatic steatosis, Fatty liver, Focal fatty sparing, Ga68 PET/CT, Hypervascularity, Indium 111-pentetreotide, Invisible illness, Magnetic resonance imaging (MRI) scan, Octreotide scan, Somatostatin receptors (SSTR), SSTR-PET, Triglycerides
In my post entitled "If you can see it, you can detect it", I listed the different types of scanning techniques and technology to find evidence of disease in Neuroendocrine Tumours (NETs). Of course, while scans, blood and (current) marker tests can give some pretty big and important clues, "tissue is the issue" that is most efficientEven after formal diagnosis, seeing all the tumours can be a challenge with NETs. In the article I quoted above, I indicated that scans for NETs can be analogous to picking 'horses for courses'. For example, most NETs have somatostatin receptors and can often…